Revisor Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$211K Buy
421
+11
+3% +$5.28K 0.05% 351
2026
Q1
$202K Buy
410
+1
+0.2% +$543 0.06% 316
2025
Q4
$262K Hold
409
0.07% 262
2025
Q3
$219K Buy
+409
New +$190K 0.08% 252

Other funds holding TMO

Revisor Wealth Management's TMO Position: Q2 2026 in Review

Revisor Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 2.7% in Q2 2026, buying an estimated $5.28K and bringing the position to 421 shares worth $211K. The position accounts for 0.05% of the portfolio, ranked #351.

Revisor Wealth Management first reported a position in TMO in Q3 2025 and has held it in 4 quarters since. The position peaked at $262K in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Revisor Wealth Management held 421 shares of Thermo Fisher Scientific worth $211K as of Q2 2026.
  • Revisor Wealth Management bought 11 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.28K.
  • Thermo Fisher Scientific made up 0.05% of Revisor Wealth Management's portfolio in Q2 2026, its #351 holding.
  • Revisor Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 4 quarters since.
  • Revisor Wealth Management's Thermo Fisher Scientific position peaked at $262K in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.